Related references
Note: Only part of the references are listed.Successful expanded access use of rezafungin, a novel echinocandin, to eradicate refractory invasive candidiasis in a liver transplant recipient
Joseph Pechacek et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial
George R. Thompson et al.
CLINICAL INFECTIOUS DISEASES (2021)
Invasive Candidiasis Species Distribution and Trends, United States, 2009-2017
Emily E. Ricotta et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Rezafungin: a novel antifungal for the treatment of invasive candidiasis
Young Yoon Ham et al.
FUTURE MICROBIOLOGY (2021)
982. Effect of Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin
Jade Huguet et al.
Open Forum Infectious Diseases (2021)
Population Pharmacokinetics of Rezafungin in Patients with Fungal Infections
Christopher M. Rubino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Estimation of Direct Healthcare Costs of Fungal Diseases in the United States
Kaitlin Benedict et al.
CLINICAL INFECTIOUS DISEASES (2019)
We can do better: a fresh look at echinocandin dosing
Justin C. Bader et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Invasive candidiasis
Peter C. Pappas et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults
Taylor Sandison et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model
Yanan Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters
Elizabeth A. Lakota et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
CD101: a novel long-acting echinocandin
Yanan Zhao et al.
CELLULAR MICROBIOLOGY (2016)
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
Mahipal G. Sinnollareddy et al.
CRITICAL CARE (2015)
Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Tissue Penetration of Antifungal Agents
Timothy Felton et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
Marin Kollef et al.
CLINICAL INFECTIOUS DISEASES (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Pharmacodynamics of Echinocandins against Candida glabrata: Requirement for Dosage Escalation To Achieve Maximal Antifungal Activity in Neutropenic Hosts
Susan J. Howard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2007)
Anidulafungin versus fluconazole for invasive candidiasis
Annette C. Reboli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
Ernst-Ruediger Kuse et al.
LANCET (2007)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia
L Ostrosky-Zeichner et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
J Mora-Duarte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
